Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.
about
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsQuality of Care Is Improved by Rapid Short Incubation MALDI-ToF Identification from Blood Cultures as Measured by Reduced Length of Stay and Patient Outcomes as Part of a Multi-Disciplinary Approach to Bacteremia in Pediatric PatientsMultiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid testPseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatmentTiming of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremiaComparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.New developments in the treatment of gram-negative bacteremia.Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strainsEstimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shockStratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosisProinflammatory cytokines in antilipopolysaccharide immunity against Klebsiella infectionsImpact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.The role of the infectious diseases physician in setting guidelines for antimicrobial useAntibiotic therapy in aging patients.Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelaePurification, toxicity, and antiendotoxin activity of polymyxin B nonapeptideSub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae.Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection.Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremiaPassive immunization of mice against Klebsiella aerogenes.Combination therapy for treatment of infections with gram-negative bacteria.Vaccination against Klebsiella aerogenes.Clinical implications of positive blood cultures.Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia.Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia.Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumoniaSurface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigensSynthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharidesVaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.Purification and vaccine potential of Klebsiella capsular polysaccharides.
P2860
Q24550738-1D2E33D4-A0FD-43DD-BB49-B20C572E897CQ28553453-A3D3C0EB-0FEE-4CC5-B832-97D0F422F30EQ28680724-8A8ABD5D-E223-4899-B419-183C99F1F023Q33722082-D029386D-8B4C-4418-8C44-AE9DCA60C8CBQ33730706-6DF03A06-4F8D-416B-99CD-59CDDFC6E314Q33751103-F17458F2-BF78-4885-8DED-3CB902893781Q33752721-5DFF29A9-3D88-42B7-881E-2A885522E50CQ33753873-63980A25-DF16-4919-B008-7A5C46407375Q34193370-498ECDD5-06FA-460D-8266-1015608498E7Q34443686-4A65D054-21F3-4557-B406-0CF13130DE32Q34526632-72B4A478-5BFD-471F-8178-5341A93493F2Q34540420-7BC354A9-B001-41AD-8C17-56687037B79DQ34564604-32C6C355-ABE5-4111-80B1-D93BE42B3491Q34922307-1FF998E2-6466-4E26-9BF9-5A93E07FB180Q34945600-C9ED4FC8-D14B-45B7-A198-6B7051CF322EQ35091494-41DF4F90-9C34-49CB-9D14-4A5DFEC4C2B7Q35119823-BF899274-6357-4E42-B50C-29E62836BA0AQ35119901-FADE8893-A065-4994-9D2A-BEEB3EAA2E7CQ35136181-D0D948A4-7050-42EE-9F28-4EC2BB3E3E02Q35229830-FCCF2333-15F9-4ADF-841B-5A3AC9D00CC1Q35347169-F3989B8D-1522-4A62-83B7-7AC9A178F417Q35540127-65D11E5C-720E-4523-BA84-B84D70D18095Q35546585-D2FDC48D-DBCA-4A2D-860B-2EBE552AEC83Q35575338-95C8A565-BF41-47F6-BD3D-967A391B8C4DQ35577947-3478E464-7CDF-48FD-9366-673DF44A3921Q35647791-27FCBE78-052B-4265-8381-7E765745CBE8Q36050878-CCE00235-73AA-455D-815D-669CD6736AD4Q36156077-92D77123-0D92-4D69-9CB0-8AC6B5607E66Q36249968-78CA8F4C-E3C1-42E7-AA6B-969B1A5CEEDBQ36635540-86382282-4CC0-4458-A912-934921A51FA4Q36667202-48D2F67C-1564-4BCD-98F0-6DC7E9FC107CQ36729974-4469E909-83BE-466E-8C0B-E1A603534ACAQ36870904-55945A3C-6194-4E29-8734-FB05E80E5D24Q36944503-815FC056-8335-4A18-AD4F-F81E4FC59CA2Q36964745-D1766AD1-C6D8-4872-9DDC-A02CC498C0A5Q36976544-4D9F63AF-3137-4F68-936E-A74B301EF837Q37007144-97742B7A-080B-44F9-B656-9145AEE54190Q37020499-3D2BBE0B-2A03-479D-8BC7-4930B6280AD6Q37024140-5168AA4C-E9BF-4DC1-B14B-6FBE8A46FBC1Q37053173-6B602E1B-3D4A-4110-AB3B-1C4356CB222E
P2860
Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Analysis of 1,186 episodes of ...... ects of antimicrobial therapy.
@en
type
label
Analysis of 1,186 episodes of ...... ects of antimicrobial therapy.
@en
prefLabel
Analysis of 1,186 episodes of ...... ects of antimicrobial therapy.
@en
P2093
P356
P1476
Analysis of 1,186 episodes of ...... fects of antimicrobial therapy
@en
P2093
E R Brenner
K L Reynolds
P304
P356
10.1093/CLINIDS/5.4.629
P577
1983-07-01T00:00:00Z